The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...

Two classic translational blocks are compounded by an execution gap characterized by weak cross-functional mobilization, slow ...

Spotlight Symposia Series will honor Soo-Kyung Lee, whose work is driven by her daughter’s rare neurodevelopmental disorder.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

A drug developed at UB to treat FOXG1 syndrome has been cleared by the U.S. Food and Drug Administration to begin clinical trials. The agency approved an Investigational New Drug (IND) application for ...